PARAMUS, NJ — Bergen New Bridge Medical Center is excited to announce the addition of in-house chemistry testing for SARS-CoV-2 (COVID-19) IgG Spike protein, semi-quantitative assay. This COVID-19 antibody testing uses the Abbott platform and has received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA). It detects COVID-19 antibodies that are generated as part of the immune response to recent or prior infection or as vaccine response. Current tests approved for use for antibody testing do not test for antibodies generated from a vaccine. This test will help physicians recognize vaccine generated immunity vs. autoimmunity from prior infection in their patients and is part of the Medical Center’s ongoing effort to expand its scope of services, improve testing result timeframes, and help better serve the needs of its communities.
“I am proud to continue to lead the way in COVID-19 mitigation and management,” said Bergen New Bridge Medical Center President and CEO, Deborah Visconi. “As we work toward achieving community immunity, this test will become an essential weapon in our COVID-19 arsenal so those who have had the virus, or received the vaccine, can begin to understand and gauge their levels of immunity. This information will be essential to track our continued virus protection as we emerge from this pandemic.”
It is important to note that negative results of this test do not rule out current COVID-19 infection. Those interested in obtaining this test at Bergen New Bridge Medical Center and have had COVID-19 should wait 15 days or more from the date they first experienced symptoms or, if asymptomatic, from their diagnosis date. The test requires a physician’s prescription. Those interested in getting tested should call 201.225.7130 to schedule an appointment for the test if they already have a prescription for it or to schedule a physician consultation regarding obtaining a test prescription.
For more information visit newbridgehealth.org.
ABOUT BERGEN NEW BRIDGE MEDICAL CENTER
Bergen New Bridge Medical Center (BNBMC), a clinical affiliate of Rutgers, is a 1,070-bed hospital located at 230 East Ridgewood Avenue in Paramus, NJ. The Medical Center is both the largest hospital and licensed nursing home in NJ and the fourth-largest publicly-owned hospital in the nation.
Bergen New Bridge Medical Center, a not-for-profit safety net facility, provides high-quality comprehensive services, including acute and ambulatory care from Rutgers New Jersey Medical School and community physicians, mental health and substance use disorder treatment, and long-term care to the greater Bergen County community. The Medical Center, including its Long-Term Care Division, is fully accredited by The Joint Commission and is in network with all major New Jersey commercial insurance plans covering 99.91% of NJ residents.
Bergen New Bridge Medical Center is a full-service hospital with a 24/7 emergency department, surgical suites, physical rehabilitation, pharmacy, laboratory, radiologic services (including digital mammography), and more than 26 medical specialties available through its Ambulatory Care Center. The Medical Center is a Veterans Community Care Provider proudly serving the healthcare needs of veterans and is a Leader in LGBTQ Healthcare Equality in the Human Rights Campaign (HRC) Healthcare Equality Index (HEI) for 2020. Learn more at www.newbridgehealth.org.